Condition 1: Type II diabetic. Condition 2: Cardiovascular disease. Type 2 diabetes mellitus Chronic ischaemic heart disease
Conditions
Interventions
Intervention 1: Intervention group: The intervention group will receive 0.2 units/kg glargine insulin 2 hours before the surgery. Based on the Van den Berghe national protocol, regular insulin injecti
accordingly, each patient will receive 4 units of regular subcutaneous insulin injection for every 40. Intervention 2: Control group: The control group will receive 0.2 units/kg dextrose 5% 2 hours be
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age of 35-65 years Sustaining ASA II Blood sugar of 150-350 mg/dl Lack of a simultaneous emergency surgery or heart valve surgery
Exclusion criteria
Exclusion criteria: Having underlying diseases (e.g., pulmonary, liver, kidney, thyroid, and digestive diseases) Having history of open-heart surgery Fever Trauma Carotid artery involvement Sensitivity to insulin glargine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glucose. Timepoint: Before the surgery, every 2 hours intraoperatively, and every 4-24 hours after the surgery. Method of measurement: Glucose meter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Long hospital days in ICU. Timepoint: After intervention. Method of measurement: The questionnaire.;Type of antibiotic used. Timepoint: After intervention. Method of measurement: The questionnaire.;Wound dehiscence. Timepoint: After intervention. Method of measurement: The questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShima Sheybani
Mashhad University of Medical Sciences
Outcome results
None listed